Analysis | Metabolite Name | Measured Value | Units | AGE | Assay | DISEASE_STATE | Timepoint |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 33965 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 76319 | Peak area normalized | 15 | OGTT | PCOS | 90 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 82841 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 87554 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 93632 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 96256 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 101946 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 103495 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 105055 | Peak area normalized | 14 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 109610 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 111142 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 113767 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 114351 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 116718 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 120143 | Peak area normalized | 14 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 122008 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 122786 | Peak area normalized | 15 | OGTT | PCOS | 30 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 123180 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 123647 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 123995 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 124132 | Peak area normalized | 15 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 125678 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 126188 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 128782 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 129264 | Peak area normalized | 14 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 130324 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 130557 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 130734 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 131756 | Peak area normalized | 14 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 139639 | Peak area normalized | 13 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 141938 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 142084 | Peak area normalized | 14 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 143352 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 143658 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 144378 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 146387 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 147273 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 149576 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 150433 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 151356 | Peak area normalized | 17 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 153059 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 153117 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 158178 | Peak area normalized | 15 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 158234 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 158460 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 158501 | Peak area normalized | 17 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 158946 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 159901 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 160206 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 160321 | Peak area normalized | 17 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 161558 | Peak area normalized | 14 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 161630 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 161697 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 164063 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 164217 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 164643 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 168347 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 169591 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 170840 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 172102 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 172828 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 175266 | Peak area normalized | 13 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 176380 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 177221 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 178216 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 178677 | Peak area normalized | 17 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 179296 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 179729 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 182913 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 183836 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 185267 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 185706 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 188207 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 188784 | Peak area normalized | 13 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 189035 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 189896 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 193252 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 203577 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 205379 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 208822 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 213563 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 223836 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 230796 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 244247 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 249825 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 274446 | Peak area normalized | 13 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | 291474 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | 15 | BC TP | PCOS | - | |
Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (M+CL)- | Peak area normalized | 15 | OGTT | PCOS | - |